Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-03

Clinical Trial Update: 18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma [EARLY_Phase 1]

View source ↗

Summary

This report updates an early-phase 1 trial using 18F-fluorodopamine PET imaging in neuroblastoma and pheochromocytoma. The study is currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 18F-Fluorodopamine PET tracer (fluorodopamine)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Neuroblastoma, Pheochromocytoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING